SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-033466
Filing Date
2024-04-16
Accepted
2024-04-16 16:33:17
Documents
74
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0203762-10k_aditxt.htm   iXBRL 10-K 2634780
2 CONSENT OF DBBMCKENNON, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea020376201ex23-1_aditxt.htm EX-23.1 1783
3 CERTIFICATION ea020376201ex31-1_aditxt.htm EX-31.1 10629
4 CERTIFICATION ea020376201ex31-2_aditxt.htm EX-31.2 10651
5 CERTIFICATION ea020376201ex32-1_aditxt.htm EX-32.1 5166
6 CLAWBACK POLICY ea020376201ex97-1_aditxt.htm EX-97.1 45656
  Complete submission text file 0001213900-24-033466.txt   10539641

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE adtx-20231231.xsd EX-101.SCH 82495
8 XBRL CALCULATION FILE adtx-20231231_cal.xml EX-101.CAL 47038
9 XBRL DEFINITION FILE adtx-20231231_def.xml EX-101.DEF 452048
10 XBRL LABEL FILE adtx-20231231_lab.xml EX-101.LAB 778741
11 XBRL PRESENTATION FILE adtx-20231231_pre.xml EX-101.PRE 445013
78 EXTRACTED XBRL INSTANCE DOCUMENT ea0203762-10k_aditxt_htm.xml XML 1217652
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39336 | Film No.: 24848226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)